6 Drug Stocks Unworthy of Biotech Bull Market

Description:

According to Adam Feuerstein, here are "six biotech and drug stocks with valuations reaching unsustainable levels or which, for various reasons, don't deserve an invitation to the biotech bull market party at all." Read more here.

>>Also: 6 Stocks With Double-Digits Gains and Big Dividends

>>Also: 3 Tech Turnaround Stocks for 2012

Most Viewed Portfolios

View All

Articles

Time to Sell These 5 'Toxic' Stocks

11.21.14 | 11:27 AM

BALTIMORE ( Stockpickr) -- Which stocks should I buy? It's the eternal question that most investors spend most of their time wondering. But is it t...

5 Earnings Short-Squeeze Plays

11.20.14 | 09:26 PM

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tra...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter